The FDA-approved products are injectable tirzepatide
Pediatr Dermatol 32:536538 Natarajan E (2019) Black and brown oro-facial mucocutaneous neoplasms
Key questions to discuss include: Whether you meet NHS criteria for GLP-1 prescription (type 2 diabetes or obesity with complications) The evidenceor lack thereoffor GLP-1 use specifically in Hashimoto's management Potential interactions between GLP-1 medications and thyroid hormone replacement How GLP-1 therapy might affect your thyroid function monitoring schedule Alternative evidence-based approaches to managing metabolic symptoms in Hashimoto's The costs and practicalities of private prescription if NHS funding is not available Contraception requirements if you are of childbearing potential (GLP-1 medications should be avoided in pregnancy and breastfeeding) Your GP may recommend optimising your current thyroid management first , ensuring your levothyroxine dose is appropriate and that you are not over- or under-replaced
Qualification for semaglutide depends on the specific drug and its uses or indications approved by the US Food and Drug Administration (FDA)
Ready access helps patients stay on plan and address issues quickly, which supports better longterm outcomes and satisfaction
Preparation strategies that improve outcomes include stocking your kitchen with easily digestible proteins and bland foods for the nausea period, purchasing ginger tea, ginger candies, and other natural anti-nausea remedies, ensuring you have adequate supplies for hydration including electrolyte drinks, scheduling the first few weeks to minimize commitments during the adjustment period, and informing close family or friends about your treatment so they can provide support